In pancreatic cancer, the histidine triad nucleotide binding protein 2 (HINT2) was showed to promote cell death, and Chen et al. showed that treatment with ruthenium red, an inhibitor of MCU, reduced HINT2-dependent-induced apoptosis. This evidence concerns the gene HINT2 and pancreatic neoplasm.